MedTrace Logo

S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone

NCT00096213 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-01-18

No results posted yet for this study

Summary

RATIONALE: Intralesional resection is a less invasive type of surgery for chondrosarcoma of the bone and may have fewer side effects and improve recovery.

PURPOSE: This phase II trial is studying how well intralesional resection works in treating patients with low-grade chondrosarcoma of the bone.

Conditions

  • Sarcoma

Interventions

PROCEDURE

conventional surgery

surgery

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • American College of Surgeons

    collaborator OTHER

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • R. Lor Randall, MD, FACS · University of Utah

  • Janet S. Biermann, MD · University of Michigan Rogel Cancer Center

  • Edward Cheng, MD · Masonic Cancer Center, University of Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2006-04-30
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00096213 on ClinicalTrials.gov